NCT04605848

Brief Summary

Patients affected by pheochromocytoma (PHEO) have brown-adipose tissue (BAT) hyperactivation. They perform, in routine settings, a FDG PET-CT scan. The high metabolic activity of BAT and its ability to consume both glucose and fatty acid suggest that it may have potential as a therapeutic target in the treatment of obesity. However, alternative non-invasive techniques to PET-CT BAT detection still need more validation. Accordingly, our aim will be to measure the temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test in PHEO patients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
7

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 3, 2020

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

October 8, 2020

Completed
20 days until next milestone

First Posted

Study publicly available on registry

October 28, 2020

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 29, 2022

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2023

Completed
Last Updated

May 9, 2024

Status Verified

May 1, 2024

Enrollment Period

1.8 years

First QC Date

October 8, 2020

Last Update Submit

May 7, 2024

Conditions

Keywords

pheochomocytomabrown adipose tissueinfrared thermographycutaneous microcirculationPET-CT

Outcome Measures

Primary Outcomes (3)

  • Skin temperature in supra-clavicular region in basal condition (TSCRbasal)

    Skin temperature in supra-clavicular region will be recorded by infrared thermography (FLIR camera) in basal condition

    Day 0

  • Skin temperature in supra-clavicular region during a cold test (TSCRcold)

    Skin temperature in supra-clavicular region will be recorded by infrared thermography (FLIR camera) during a cold test (feet in water at 19°C during 20min)

    Day 0

  • Baseline difference in skin temperature in supra-clavicular region (diff TSCR)

    diff TSCR (day 0) = TSCRcold - TSCRbasal

    Day 0

Secondary Outcomes (9)

  • Cutaneous blood flow in supra-clavicular region in basal condition (PUbasal)

    Day 0

  • Cutaneous blood flow in supra-clavicular region during a cold test (PUcold)

    Day 0

  • Baseline difference in cutaneous blood flow in supra-clavicular region (∆PU)

    Day 0

  • Volume of Brown Adipose Tissue detected by PET-CT

    Day 0

  • Activity of Brown Adipose Tissue detected by PET-CT

    Day 0

  • +4 more secondary outcomes

Study Arms (1)

BAT group

EXPERIMENTAL

Patients will be divided in two groups for statistical analysis: * patients with detectable BAT by PET-CT (BAT+) * patients with no detectable BAT by PET-CT (BAT-)

Diagnostic Test: Infrared themrography

Interventions

Infrared themrographyDIAGNOSTIC_TEST

measurement of temperature and microcirculation of the skin overlaying BAT depots in the region of FDG-uptake detected by 18F-FDG PET/CT before and after a cold test

Also known as: Cutaneous microcirculation
BAT group

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with confirmed pheochromocytoma and/or paraganglioma

You may not qualify if:

  • pregnant woman
  • breastfeeding woman

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pôle ENDO- Hopital la Conception APHM

Marseille, PACA, 13385, France

Location

MeSH Terms

Conditions

PheochromocytomaParaganglioma

Condition Hierarchy (Ancestors)

Neuroendocrine TumorsNeuroectodermal TumorsNeoplasms, Germ Cell and EmbryonalNeoplasms by Histologic TypeNeoplasmsNeoplasms, Nerve Tissue

Study Officials

  • Françoise Latil-Plat

    Centre Hospitalier Henri Duffaut - Avignon

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 8, 2020

First Posted

October 28, 2020

Study Start

July 3, 2020

Primary Completion

April 29, 2022

Study Completion

October 20, 2023

Last Updated

May 9, 2024

Record last verified: 2024-05

Locations